(SFD) Smithfield Foods, Common - Overview
Sector: Consumer Defensive | Industry: Packaged Foods | Exchange: NASDAQ (USA) | Market Cap: 10.364m USD | Total Return: 19.8% in 12m
Avg Turnover: 31.9M
Qual. Beats: 0
Rev. Trend: 62.4%
Warnings
No concerns identified
Tailwinds
Idiosyncratic Leader
Smithfield Foods, Inc. is a vertically integrated producer of packaged meats and fresh pork products with operations spanning hog production, processing, and international distribution. The company maintains a diverse portfolio of consumer brands, including Nathans Famous, Eckrich, and Armour, while also supplying private-label products to retail and foodservice sectors. Its business model leverages vertical integration to control costs and supply chain logistics from livestock feed production to final distribution.
The company operates through four primary segments: Packaged Meats, Fresh Pork, Hog Production, and a specialized Bioscience division that manufactures pharmaceutical ingredients like heparin from porcine raw materials. In the Packaged Foods & Meats industry, large-scale processors often utilize export markets to offset domestic demand fluctuations, and Smithfield maintains significant trade channels in China, Mexico, and Japan. Investors can utilize ValueRay to further analyze the companys valuation metrics and historical performance.
Founded in 1936 and headquartered in Virginia, Smithfield Foods functions as a subsidiary of SFDS UK Holdings Limited. The Hog Production segment utilizes both company-owned facilities and third-party contract farmers to maintain its livestock pipeline. This structure allows the firm to manage the volatility of grain and livestock prices while serving a global customer base across industrial and commercial channels.
- Fluctuating feed grain costs directly impact hog production segment profitability
- Global pork export demand shifts influence fresh pork segment revenue margins
- Consumer shift toward value-based packaged meats affects retail sales volume
- Stringent environmental and animal welfare regulations increase operational compliance costs
- Vertical integration efficiency determines margins across hog production and processing segments
| Net Income: 1.01b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA -0.41 > 1.0 |
| NWC/Revenue: 18.93% < 20% (prev 20.33%; Δ -1.40% < -1%) |
| CFO/TA 0.10 > 3% & CFO 1.16b > Net Income 1.01b |
| Net Debt (1.39b) to EBITDA (1.67b): 0.83 < 3 |
| Current Ratio: 2.41 > 1.5 & < 3 |
| Outstanding Shares: last quarter (394.7m) vs 12m ago 0.40% < -2% |
| Gross Margin: 13.43% > 18% (prev 0.14%; Δ 1.33k% > 0.5%) |
| Asset Turnover: 134.4% > 50% (prev 129.8%; Δ 4.63% > 0%) |
| Interest Coverage Ratio: 35.29 > 6 (EBITDA TTM 1.67b / Interest Expense TTM 38.0m) |
| A: 0.25 (Total Current Assets 5.03b - Total Current Liabilities 2.09b) / Total Assets 12.0b |
| B: 0.32 (Retained Earnings 3.90b / Total Assets 12.0b) |
| C: 0.12 (EBIT TTM 1.34b / Avg Total Assets 11.6b) |
| D: 0.74 (Book Value of Equity 3.57b / Total Liabilities 4.83b) |
| Altman-Z'' = 4.22 = AA |
| DSRI: 1.31 (Receivables 1.07b/759.0m, Revenue 15.6b/14.5b) |
| GMI: 1.05 (GM 13.43% / 14.13%) |
| AQI: 0.94 (AQ_t 0.28 / AQ_t-1 0.30) |
| SGI: 1.08 (Revenue 15.6b / 14.5b) |
| TATA: -0.01 (NI 1.01b - CFO 1.16b) / TA 12.0b) |
| Beneish M = -2.72 (Cap -4..+1) = A |
As of May 27, 2026, the stock is trading at USD 26.25 with a total of 1,242,971 shares traded.
Over the past week, the price has changed by +2.20%,
over one month by -7.50%,
over three months by +9.04% and
over the past year by +19.80%.
Smithfield Foods, Common has received a consensus analysts rating of 4.38. Therefore, it is recommended to buy SFD.
- StrongBuy: 4
- Buy: 3
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 31.4 | 19.5% |
P/E Trailing = 10.249
P/E Forward = 10.2354
P/S = 0.6661
P/B = 1.5099
Revenue TTM = 15.6b USD
EBIT TTM = 1.34b USD
EBITDA TTM = 1.67b USD
Long Term Debt = 1.40b USD (from longTermDebt, last quarter)
Short Term Debt = 675.0m USD (from shortTermDebt, last quarter)
Debt = 2.77b USD (from shortLongTermDebtTotal, last quarter) + Leases 386.0m
Net Debt = 1.39b USD (calculated: Debt 2.77b - CCE 1.39b)
Enterprise Value = 11.8b USD (10.4b + Debt 2.77b - CCE 1.39b)
Interest Coverage Ratio = 35.29 (Ebit TTM 1.34b / Interest Expense TTM 38.0m)
EV/FCF = 14.44x (Enterprise Value 11.8b / FCF TTM 814.0m)
FCF Yield = 6.93% (FCF TTM 814.0m / Enterprise Value 11.8b)
FCF Margin = 5.23% (FCF TTM 814.0m / Revenue TTM 15.6b)
Net Margin = 6.48% (Net Income TTM 1.01b / Revenue TTM 15.6b)
Gross Margin = 13.43% ((Revenue TTM 15.6b - Cost of Revenue TTM 13.5b) / Revenue TTM)
Gross Margin QoQ = 13.45% (prev 14.24%)
Tobins Q-Ratio = 0.98 (Enterprise Value 11.8b / Total Assets 12.0b)
Interest Expense / Debt = 1.37% (Interest Expense 38.0m / Debt 2.77b)
Taxrate = 22.43% (72.0m / 321.0m)
NOPAT = 1.04b (EBIT 1.34b * (1 - 22.43%))
Current Ratio = 2.41 (Total Current Assets 5.03b / Total Current Liabilities 2.09b)
Debt / Equity = 0.40 (Debt 2.77b / totalStockholderEquity, last quarter 6.86b)
Debt / EBITDA = 0.83 (Net Debt 1.39b / EBITDA 1.67b)
Debt / FCF = 1.71 (Net Debt 1.39b / FCF TTM 814.0m)
Total Stockholder Equity = 6.61b (last 4 quarters mean from totalStockholderEquity)
RoA = 8.71% (Net Income 1.01b / Total Assets 12.0b)
RoE = 15.25% (Net Income TTM 1.01b / Total Stockholder Equity 6.61b)
RoCE = 16.74% (EBIT 1.34b / Capital Employed (Equity 6.61b + L.T.Debt 1.40b))
RoIC = 9.87% (NOPAT 1.04b / Invested Capital 10.5b)
WACC = 5.58% (E(10.4b)/V(13.1b) * Re(6.79%) + D(2.77b)/V(13.1b) * Rd(1.37%) * (1-Tc(0.22)))
Discount Rate = 6.79% (= CAPM, Blume Beta Adj.)
[DCF] Terminal Value 75.64% ; FCFF base≈809.2m ; Y1≈822.7m ; Y5≈893.3m
[DCF] Fair Price = 31.69 (EV 13.9b - Net Debt 1.39b = Equity 12.5b / Shares 393.5m; r=8.35% [WACC [floored]]; 5y FCF grow 1.50% → 2.50% )
EPS Correlation: N/A | EPS CAGR: N/A | SUE: 0.69 | # QB: 0
Revenue Correlation: 62.36 | Revenue CAGR: 3.00% | SUE: N/A | # QB: 0
EPS current Quarter (2026-06-30): EPS=0.65 | Chg30d=-3.36% | Revisions=-25% | Analysts=4
EPS next Quarter (2026-09-30): EPS=0.64 | Chg30d=-4.99% | Revisions=-25% | Analysts=4
EPS current Year (2026-12-31): EPS=2.69 | Chg30d=+0.56% | Revisions=-11% | GrowthEPS=+5.3% | GrowthRev=+1.7%
EPS next Year (2027-12-31): EPS=2.60 | Chg30d=-0.73% | Revisions=+0% | GrowthEPS=-3.3% | GrowthRev=+0.8%
[Analyst] Revisions Ratio: -25%